Where GWAS and Epidemiology Meet: Opportunities for the Simultaneous Study of Genetic and Environmental Risk Factors in Schizophrenia
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Epidemiologists and geneticists have tended to explore their respective domains independently, and as a consequence, these fields have drifted apart. The aim of this article is to outline how clues from genetics and epidemiology can be combined in order to optimize schizophrenia research. In particular, we will explore how recent developments in statistical genetics might be used to leverage clues from epidemiology. The ultimate goal of this type of research is to help generate better treatments for schizophrenia via the identification of shared pathways1 and to find modifiable risk factors that could lead to the primary prevention of schizophrenia.2 Epidemiological studies in schizophrenia have been based on population-based surveys, case-control studies, or cohort studies. Access to large, population-based mental health registers, especially in Nordic countries, has strongly influenced psychiatric epidemiology. These studies have provided population-based estimates for a wide range of risk factors (eg, urban birth, paternal age, psychiatric family history, and infections) and have been strengthened by design features such as the avoidance of selection bias and control of multiple confounders. In contrast, genetic samples have traditionally been recruited from (a) informative samples (eg, multiplex families and isolated populations) or (b) convenient samples (eg, cases recruited from attendees at mental health services). The recruitment of large, representative samples of cases from national registers is feasible in some nations. While some research precision is lost through the use of administrative diagnoses, this can be balanced against the gain in accuracy through large sample sizes and the knowledge that subsequent results are broadly representative of national clinical practice. The recruitment of large, representative samples of controls is more widely achievable. For example, The Wellcome Trust Case Control Consortium used the large UK 1958 birth cohort as the “healthy control” sample in their landmark studies.3 Studies related to the genetics of schizophrenia that have recruited large samples based on national registers have been published.4–6 In the absence of direct genetic data, researchers have relied on various parameters derived from familial aggregation. These have ranged from simple dichotomies (eg, family history present vs absent) to more quantitative metrics (eg, sibling recurrence risk ratio and heritability estimated from cohorts of twins or families). The recurrence of a disorder in different family members suggests that genetic factors and/or shared environmental factors within the family contribute to disease risk. By examining the risk of the disorder in certain relatives (eg, first-degree vs second-degree relatives and monozygotic vs dizygotic twins) and by making assumptions about the degree of shared environment (eg, twins raised together are more likely to experience similar environments), attempts can be made to separate contributions of genetic and non-genetic factors providing clues to the risk architecture of disorders. Parameters such as heritability7 and sibling recurrence risk8 have played an important role in guiding genetic studies over recent decades. Patients with schizophrenia are routinely asked about the presence or absence of other family members with this disorder—indeed family history can be a feature in some diagnostic checklists. While easy to ask, this variable has its limitations as a measure of genetic susceptibility because the absence of known family history may be a poor measure of heritable factors9 and family history may be poorly recorded.10 Furthermore, a family history of a broad range of nonpsychotic disorders has also been linked to the risk of schizophrenia.11 Despite these limitations, family history is an important positive predictor12,13 and has been informative in schizophrenia research—studies have explored the association between (a) urbanicity and family history,14 (b) cannabis use and family history,15,16 and (c) trauma exposure and family history.17 In twin or family studies, it is feasible to stratify subjects by candidate exposures of interest in order to explore the impact of this variable on estimates of heritability or sibling recurrence risk.18 The relative influence of environmental factors to heritability estimates for many neuropsychiatric phenotypes varies across the life span—thus stratifying heritability estimates by age range can provide clues to the relative contribution of environmental factors.19,20 “Genotype by environment interaction” (G × E) is a term frequently used in genetic epidemiology but remains the cause of much confusion—the term is used in different contexts and with different definitions. Some researchers use G × E to mean that the outcome (in our case schizophrenia) is the result of a process that involves both genetic and environmental risk factors. Others use G × E in a strict statistical sense. The pro
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Heritability in the genomics era — concepts and misconceptions
Visscher, P. M., Hill, W. G., & Wray, N. R. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2322 · Cited by 1,921
Self-citationGenetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177
Estimating Missing Heritability for Disease from Genome-wide Association Studies
Lee, S. H., Wray, N. R., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.002 · Cited by 1,064
Self-citationDuncan, L. E., & Keller, M. C. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020191 · Cited by 1,032
Bergen, S. E., Gardner, C. O., & Kendler, K. S. (2007) · Twin Research and Human Genetics · doi:10.1375/twin.10.3.423 · Cited by 461
Lenroot, R. K., Schmitt, J. E., Ordaz, S. J., Wallace, G. L., Neale, M. C., Lerch, J. P., Kendler, K. S., Evans, A. C., & Giedd, J. N. (2009) · Human Brain Mapping · doi:10.1002/hbm.20494 · Cited by 320
Recurrence risks for schizophrenia in a Swedish National Cohort
LICHTENSTEIN, P., BJÖRK, C., HULTMAN, C. M., SCOLNICK, E., SKLAR, P., & SULLIVAN, P. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706008385 · Cited by 197
Perlis, R. H., Iosifescu, D. V., Castro, V. M., Murphy, S. N., Gainer, V. S., Minnier, J., Cai, T., Goryachev, S., Zeng, Q., Gallagher, P. J., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711000997 · Cited by 193
Cited by
Research Review: Polygenic methods and their application to psychiatric traits
Wray, N. R., Lee, S. H., Mehta, D., Vinkhuyzen, A. A. E., Dudbridge, F., & Middeldorp, C. M. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12295 · Cited by 666
Self-citationLarge-scale genomics unveils the genetic architecture of psychiatric disorders
Gratten, J., Wray, N. R., Keller, M. C., & Visscher, P. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3708 · Cited by 363
Self-citationPedersen, C. B., Bybjerg-Grauholm, J., Pedersen, M. G., Grove, J., Agerbo, E., Bækvad-Hansen, M., Poulsen, J. B., Hansen, C. S., McGrath, J. J., Als, T. D., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.196 · Cited by 338
Self-citationTreatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 304
European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI) (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu069 · Cited by 259
Metadata
- Authors
- McGrath, J. J., Mortensen, P. B., Visscher, P. M., & Wray, N. R.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-08-01
- Volume
- 39
- Issue
- 5
- Pages
- 955-959
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2117191552
- Cited by
- 82
- References
- 16
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Where GWAS and Epidemiology Meet: Opportunities for the Simultaneous Study of Genetic and Environmental Risk Factors in Schizophrenia. https://app.cochat.ai/papers/10.1093/schbul/sbt108
- The paper
- McGrath, J. J., Mortensen, P. B., Visscher, P. M., & Wray, N. R. (2013). Where GWAS and Epidemiology Meet: Opportunities for the Simultaneous Study of Genetic and Environmental Risk Factors in Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbt108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.